// App-Quantinova.ai

2318 : Discovery and validation of a novel checkpoint target preferentially expressed in the tumor microenvironment

Researchers

Presenter

  • Narendiran Rajasekaran

Principal Investigators

  • Amani Makkouk

  • Russel K. Pachynski

  • Aruna Azameera

  • Cariad Chester

  • Xing Zhao

  • Atsushi Yonezawa

  • Holbrook E. Kohrt

Medical Centers

  • Washington University School of Medicine, St. Louis, MO

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A